Decisions about add-on reimbursement for medical devices in France in January 2019

06

Feb 2019

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in January 2019. The decisions were brought for eighteen (18) medical devices.

Four (4) decision was released regarding prostheses:

  • LARS, Artificial ligament for the knee (application for renewal of registration, approved; application for amendment of the registration conditions, rejected due to the lack of clinical data provided)
  • DURASUL (insert and acetabulum), acetabular cup and monoblock insert in highly cross-linked polyethylene (canceled)
  • DURASUL (acetabulum), one-piece cup in highly cross-linked polyethylene (application for renewal of registration, approved; application for amendment of the registration conditions, rejected due to the lack of clinical data provided for one additional condition, approved for the other)
  • DURASUL (insert), highly crosslinked polyethylene insert, (application for renewal of registration, approved; application for amendment of the registration conditions, rejected due to the lack of clinical data provided for one additional condition, approved for the other)

Four (4) decision was released regarding cardiovascular devices:

  • ELUVIA, peripheral active release stent (paclitaxel) (application for renewal of registration, approved; application for amendment of the registration conditions (two new conditions), rejected due to the lack of clinical data provided)
  • ZENITH FENESTRATED, an aortic stent (application for amendment of the registration conditions, approved)
  • REVEAL LINQ, implantable cardiac monitor (application for registration, approved)
  • YUKON CHOICE PC, coronary stent coated with sirolimus (pharmacologically active product) (application for amendment of the registration conditions, approved)

Ten (10) decisions were released regarding other devices:

  • ERIS, modular electric scooter (application for registration, approved)
  • VISCO (cushion), viscoelastic memory foam cushion (application for renewal of registration, approved)
  • AXTAIR AUTOMORPHO PLUS, alternating pressure motorized air mattress pad with associated compressor (application for registration, rejected because the available clinical data do not establish the interest for this product)
  • SONALTO, pre-set listening assistant (application for registration, rejected because the available clinical data do not establish the interest for this product)
  • SORTEZ COUVERTS, lubricated male condoms (application for registration, approved)
  • SNAP Therapy System, negative pressure wound treatment system (application for registration, rejected because the available clinical data do not establish the interest for this product)
  • SIR-Spheres, microspheres made of Yttrium-90 (application for amendment of the registration conditions, approved)
  • MOBIDERM (standard), limb compression devices (application for registration, rejected)
  • ExEm Foam Kit FK05, preparation kit for the hyperechoic product (application for registration, approved)
  • FREESTYLE OPTIUM BETA CETONE, an electrode for measuring ketone (application for renewal of registration, approved)

See the full list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more